- Article
Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia
- Zhengli Bai,
- Menglong Xu,
- Ying Mei,
- Tuo Hu,
- Panpan Zhang,
- Manman Chen,
- Wenxiu Lv,
- Chenchen Lu and
- Shuhua Tan
Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) has become an attractive therapeutic strategy for lowering low-density lipoprotein cholesterol (LDL-C). In this study, a novel high affinity humanized IgG1 mAb (named h5E12-L230G) ta...